Diagnostics-As-A-Service Global Market Report 2025
상품코드:1855850
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
진단 서비스 시장 규모는 최근 급격히 확대되고 있습니다. 2024년 44억 5,000만 달러에서 2025년에는 54억 달러에 달하고, CAGR 21.2%로 확대될 전망입니다. 실적기간 내 성장은 디지털 건강 관리의 시작, 질병의 조기 발견에 대한 수요 증가, 클라우드 기반 솔루션의 광범위한 채택, 효율적인 접근이 필요한 의료비 증가, 보다 빠르고 정확한 진단에 대한 수요 증가와 관련이 있습니다.
진단 서비스 시장 규모는 향후 수년간 비약적인 성장이 예상됩니다. 2029년에는 CAGR 20.8%로 115억 달러로 성장할 전망입니다. 이 예측 기간 내 성장은 만성 질환의 유병률 증가, 맞춤 의료 확대, 원거리 및 가정에서의 검사 수요 증가, 비용 효율적인 진단에 대한 주목 고조, 디지털 헬스케어 솔루션에 대한 지원적인 규제 조치 등과 관련이 있습니다. 예측기간 중의 주요 동향으로는 AI 기반 진단의 이용, 클라우드 기반 플랫폼의 채용, 통합 멀티오믹스 접근법, 원거리 및 가정 내 검사, 디지털 리포팅에 의한 실시간 분석, 블록체인 대응 데이터 보안, 환자 중심의 맞춤 진단 서비스 등을 들 수 있습니다.
만성 질환의 유병률 증가는 향후 수년간 진단 서비스 시장의 확대를 촉진할 것으로 예측됩니다. 만성 질환은 지속적인 의료가 필요한 장기적인 건강 상태이며, 종종 정적인 라이프 스타일로 인해 발생합니다. 장시간 움직이지 않거나 신체 활동을 최소화하는 등의 행동은 심장병 및 당뇨병과 같은 질병의 발병 가능성을 높입니다. 진단 서비스는 클라우드 기반 검사 및 분석을 가능하게 함으로써 장기적인 건강 상태 모니터링을 용이하게 하고 만성 질환 관리에 중요한 역할을 합니다. 이 서비스는 적시에 인사이트를 제공하고, 빈번한 통원의 필요성을 줄이며, 만성 건강 염려증을 가진 개인의 접근을 개선함으로써 환자의 진료를 향상시킵니다. 예를 들어 2024년 6월 영국의 국민보건서비스는 2023년 361만 5,330명이 혈당 상승을 나타내는 비당뇨병성 고혈당증으로 진단되었고 2022년보다 18% 증가했다고 보고했습니다. 이 추세는 지속적인 모니터링에 대한 수요 증가를 부각시키고 진단 서비스 시장을 견인하고 있습니다.
맞춤 의료의 채용 확대도 진단 서비스 시장의 성장에 기여하고 있습니다. 맞춤 의료는 개인의 유전적 체질, 라이프 스타일, 환경에 따라 치료 및 예방 계획을 조정하는 것입니다. 이 접근법의 시작은 유전적 돌연변이의 정확한 식별과 맞춤 치료의 수립을 가능하게 하는 유전체학의 진보로 인해 발생합니다. 진단 서비스는 신속하고 정확한 환자 평가를 제공하는 클라우드 기반 진단 도구를 제공함으로써 맞춤 의료를 강화하고 있습니다. 이러한 서비스는 데이터 수집과 분석을 간소화하고, 맞춤형 치료 전략을 지원하며, 임상 결정을 개선합니다. 예를 들어, 2024년 2월 맞춤의료연합(Personalized Medicine Coalition)은 미국 식품의약국이 2023년에 26개 맞춤 신약을 승인했다고 보고했습니다. 이러한 맞춤 의료 도입의 급증은 진단 서비스 시장의 성장에 박차를 가하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 진단 서비스 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 진단 서비스 시장 : 성장률 분석
세계의 진단 서비스 시장 실적 : 규모와 성장(2019-2024년)
세계의 진단 서비스 시장 예측 : 규모와 성장(2024-2029년, 2034년)
세계의 진단 서비스 : 총 시장 규모(TAM)
제6장 시장 세분화
세계의 진단 서비스 시장 : 컴포넌트별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
소프트웨어
서비스
플랫폼
세계의 진단 서비스 시장 : 전개 모드별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
클라우드 기반
On-Premise
하이브리드
세계의 진단 서비스 시장 : 용도별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
임상 진단
영상 진단
병리학
유전체학
기타 용도
세계의 진단 서비스 시장 : 최종사용자별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
병원 및 클리닉
진단 실험실
연구기관
기타 최종 사용자
세계의 진단 서비스 시장 세분화 : 소프트웨어 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
진단 분석 소프트웨어
임상 의사 결정 지원 소프트웨어
인공지능(AI) 및 머신러닝(ML) 기반 진단 도구
영상 및 가시화 소프트웨어
데이터 통합 및 상호 운용성 소프트웨어
원격 모니터링 및 보고 소프트웨어
세계의 진단 서비스 시장 세분화 : 서비스 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
진단 검사 서비스
원격 및 가상 진단 서비스
클라우드 기반 데이터 스토리지 및 관리
컨설팅 및 구현 서비스
교육 및 지원 서비스
보수 및 업그레이드 서비스
세계의 진단 서비스 시장 세분화 : 플랫폼 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
클라우드 기반 진단 플랫폼
On-Premise 진단 플랫폼
하이브리드 전개 플랫폼
애플리케이션 프로그래밍 인터페이스(API)와 통합 플랫폼
모바일 또는 원격 진단 플랫폼
데이터 교환 및 협업 플랫폼
제7장 지역별/국가별 분석
세계의 진단 서비스 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
세계의 진단 서비스 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
진단 서비스 시장 : 경쟁 구도
진단 서비스 시장 : 기업 프로파일
F. Hoffmann-La Roche AG : 개요, 제품 및 서비스, 전략 및 재무 분석
Thermo Fisher Scientific Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Abbott Laboratories : 개요, 제품 및 서비스, 전략 및 재무 분석
Siemens Healthineers AG : 개요, 제품 및 서비스, 전략 및 재무 분석
Koninklijke Philips NV : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
GE Healthcare Technologies Inc.
Becton Dickinson and Company
Agilent Technologies Inc.
Hologic Inc.
Bio-Rad Laboratories Inc.
Guardant Health Inc.
Invitae Corporation
InHealth Group Limited
Canon Medical Systems Corporation
Freenome Holdings Inc.
BioSerenity SAS
PathAI Inc.
Butterfly Network Inc.
Aidoc Medical Ltd.
Owkin Inc.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
진단 서비스 시장(2029년) : 새로운 기회를 제공하는 국가
진단 서비스 시장(2029년) : 새로운 기회를 제공하는 부문
진단 서비스 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
CSM
영문 목차
영문목차
Diagnostics-as-a-service is a cloud-based healthcare approach that offers diagnostic testing, analysis, and reporting via digital platforms, often utilizing artificial intelligence (AI), internet of things (IoT), and remote connectivity. It provides scalable, cost-efficient, and accessible diagnostic solutions without requiring extensive on-site infrastructure. The model supports real-time health monitoring, quicker decision-making, and better patient outcomes by optimizing diagnostic delivery across healthcare environments.
The primary elements of diagnostics-as-a-service are software, services, and hardware. Software includes cloud-based platforms that deliver on-demand diagnostic testing, analysis, and reporting, facilitating scalable, cost-effective, and accessible healthcare diagnostics. It can be implemented through cloud-based, on-premises, or hybrid systems. Applications cover clinical diagnostics, imaging, pathology, genomics, and more, serving hospitals, clinics, diagnostic laboratories, research institutes, and other users.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.
The diagnostics-as-a-service market research report is one of a series of new reports from The Business Research Company that provides diagnostics-as-a-service market statistics, including the diagnostics-as-a-service industry global market size, regional shares, competitors with the diagnostics-as-a-service market share, detailed diagnostics-as-a-service market segments, market trends, and opportunities, and any further data you may need to thrive in the diagnostics-as-a-service industry. This diagnostics-as-a-service market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The diagnostics-as-a-service market size has grown exponentially in recent years. It will grow from $4.45 billion in 2024 to $5.40 billion in 2025 at a compound annual growth rate (CAGR) of 21.2%. The growth in the historic period can be linked to the rise of digital healthcare, increasing demand for early disease detection, wider adoption of cloud-based solutions, growing healthcare costs driving the need for efficient approaches, and a heightened demand for faster, more accurate diagnostics.
The diagnostics-as-a-service market size is expected to see exponential growth in the next few years. It will grow to $11.50 billion in 2029 at a compound annual growth rate (CAGR) of 20.8%. The growth in the forecast period can be linked to the rising prevalence of chronic diseases, expansion of personalized medicine, growing demand for remote and home-based testing, increased focus on cost-effective diagnostics, and supportive regulatory measures for digital healthcare solutions. Key trends during the forecast period include the use of AI-driven diagnostics, adoption of cloud-based platforms, integrated multi-omics approaches, remote and at-home testing, real-time analytics with digital reporting, blockchain-enabled data security, and patient-centric, personalized diagnostic services.
The rising prevalence of chronic diseases is expected to drive the expansion of the diagnostics-as-a-service market in the coming years. Chronic diseases are long-lasting health conditions that require ongoing medical care, often becoming more prevalent due to inactive lifestyles. Sedentary behavior, such as prolonged sitting and minimal physical activity, increases the likelihood of developing conditions such as heart disease and diabetes. Diagnostics-as-a-service plays a crucial role in managing chronic diseases by enabling cloud-based testing and analysis, which facilitates the monitoring of long-term health conditions. This service enhances patient care by providing timely insights, reducing the need for frequent hospital visits, and improving accessibility for individuals with chronic health concerns. For example, in June 2024, the National Health Service in the UK reported that 3,615,330 individuals were diagnosed with non-diabetic hyperglycemia, a condition indicating elevated blood sugar levels, in 2023, an 18% increase from 2022. This trend highlights the growing demand for continuous monitoring, driving the diagnostics-as-a-service market.
The increasing adoption of personalized medicine is also contributing to the growth of the diagnostics-as-a-service market. Personalized medicine tailors treatment and prevention plans based on an individual's genetic makeup, lifestyle, and environment. The rise of this approach is largely due to advancements in genomics, which allow for the precise identification of genetic variations and the creation of individualized treatments. Diagnostics-as-a-service enhances personalized medicine by offering cloud-based diagnostic tools that provide rapid, accurate patient assessments. These services streamline data collection and analysis, supporting customized treatment strategies and improving clinical decision-making. For instance, in February 2024, the Personalized Medicine Coalition reported that the U.S. Food and Drug Administration approved 26 new personalized medicines in 2023, a significant increase from the 12 approved in 2022. This surge in personalized medicine adoption is fueling the growth of the diagnostics-as-a-service market.
Companies in the diagnostics-as-a-service market are increasingly focusing on developing patient-centric solutions, such as at-home lab testing services, to improve convenience and accessibility. At-home lab testing services allow individuals to collect samples at home and receive test results without needing to visit a clinic. For example, in June 2025, Amazon India partnered with Orange Health Labs to launch Amazon Diagnostics, an at-home lab testing service under Amazon Medical. Available in six major cities, the service offers doorstep sample collection within 60 minutes and delivers digital reports in as little as six hours, covering over 800 diagnostic tests. Customers can book, track, and access secure test results through the Amazon app. This initiative addresses key challenges in India's diagnostic sector, such as delays, accessibility, and quality, while aligning with Amazon's broader goal of providing comprehensive healthcare services, including pharmacy and clinics.
Major players in the diagnostics-as-a-service market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Koninklijke Philips N.V., GE Healthcare Technologies Inc., Becton Dickinson and Company, Agilent Technologies Inc., Hologic Inc., Bio-Rad Laboratories Inc., Guardant Health Inc., Invitae Corporation, InHealth Group Limited, Canon Medical Systems Corporation, Freenome Holdings Inc., BioSerenity SAS, PathAI Inc., Butterfly Network Inc., Aidoc Medical Ltd., Owkin Inc., K Health Inc., and Probatix GmbH.
North America was the largest region in the diagnostics-as-a-service market in 2024. The regions covered in diagnostics-as-a-service report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the diagnostics-as-a-service market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The diagnostics-as-a-service market includes revenues earned by entities through remote diagnostic testing, laboratory analysis, sample collection and processing, cloud-based reporting, and teleconsultation for test interpretation. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Diagnostics-As-A-Service Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on diagnostics-as-a-service market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for diagnostics-as-a-service ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The diagnostics-as-a-service market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Component: Software; Services; Platforms
2) By Deployment Mode: Cloud-Based; On-Premises; Hybrid
3) By Application: Clinical Diagnostics; Imaging Diagnostics; Pathology; Genomics; Other Applications
4) By End-User: Hospitals And Clinics; Diagnostic Laboratories; Research Institutes; Other End Users
Subsegments:
1) By Software: Diagnostic Analytics Software; Clinical Decision Support Software; Artificial Intelligence (AI) Or Machine Learning (ML)-Based Diagnostic Tools; Imaging And Visualization Software; Data Integration And Interoperability Software; Remote Monitoring And Reporting Software
2) By Services: Diagnostic Testing Services; Remote And Virtual Diagnostic Services; Cloud-Based Data Storage And Management; Consulting And Implementation Services; Training And Support Services; Maintenance And Upgradation Services
3) By Platforms: Cloud-based Diagnostic Platforms; On-Premise Diagnostic Platforms; Hybrid Deployment Platforms; Application Programming Interface (API) And Integration Platforms; Mobile Or Tele-Diagnostics Platforms; Data Exchange And Collaboration Platforms
Companies Mentioned: F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; Abbott Laboratories; Siemens Healthineers AG; Koninklijke Philips N.V.; GE Healthcare Technologies Inc.; Becton Dickinson and Company; Agilent Technologies Inc.; Hologic Inc.; Bio-Rad Laboratories Inc.; Guardant Health Inc.; Invitae Corporation; InHealth Group Limited; Canon Medical Systems Corporation; Freenome Holdings Inc.; BioSerenity SAS; PathAI Inc.; Butterfly Network Inc.; Aidoc Medical Ltd.; Owkin Inc.; K Health Inc.; Probatix GmbH
3. Diagnostics-As-A-Service Market Trends And Strategies
4. Diagnostics-As-A-Service Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Diagnostics-As-A-Service Growth Analysis And Strategic Analysis Framework
5.1. Global Diagnostics-As-A-Service PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Diagnostics-As-A-Service Market Growth Rate Analysis
5.4. Global Diagnostics-As-A-Service Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Diagnostics-As-A-Service Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Diagnostics-As-A-Service Total Addressable Market (TAM)
6. Diagnostics-As-A-Service Market Segmentation
6.1. Global Diagnostics-As-A-Service Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Software
Services
Platforms
6.2. Global Diagnostics-As-A-Service Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cloud-Based
On-Premises
Hybrid
6.3. Global Diagnostics-As-A-Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Clinical Diagnostics
Imaging Diagnostics
Pathology
Genomics
Other Applications
6.4. Global Diagnostics-As-A-Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals And Clinics
Diagnostic Laboratories
Research Institutes
Other End Users
6.5. Global Diagnostics-As-A-Service Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Diagnostic Analytics Software
Clinical Decision Support Software
Artificial Intelligence (AI) Or Machine Learning (ML)-Based Diagnostic Tools
Imaging And Visualization Software
Data Integration And Interoperability Software
Remote Monitoring And Reporting Software
6.6. Global Diagnostics-As-A-Service Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Diagnostic Testing Services
Remote And Virtual Diagnostic Services
Cloud-Based Data Storage And Management
Consulting And Implementation Services
Training And Support Services
Maintenance And Upgradation Services
6.7. Global Diagnostics-As-A-Service Market, Sub-Segmentation Of Platforms, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cloud-Based Diagnostic Platforms
On-premise Diagnostic Platforms
Hybrid Deployment Platforms
Application Programming Interface (API) And Integration Platforms
Mobile Or Tele-diagnostics Platforms
Data Exchange And Collaboration Platforms
7. Diagnostics-As-A-Service Market Regional And Country Analysis
7.1. Global Diagnostics-As-A-Service Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Diagnostics-As-A-Service Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
